Patent details

EP2480575 Title: ANTAGONISTS OF DSG2 FOR TREATMENT OF CANCER

Basic Information

Publication number:
EP2480575
PCT Application Number:
GB2010001776
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107663122
PCT Publication Number:
WO2011036440
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTAGONISTS OF DSG2 FOR TREATMENT OF CANCER
French Title of Invention:
ANTAGONISTES DE DSG2 POUR LE TRAITEMENT DU CANCER
German Title of Invention:
DSG2-ANTAGONISTEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
22/09/2010
Grant date:
26/12/2018
EP Publication Date:
01/08/2012
PCT Publication Date:
31/03/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/12/2018
EP B1 Publication Date:
26/12/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/09/2019
Expiration date:
22/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/12/2018
 
 

Name:
Asclepiumm Limited
Address:
17 Block A Pollard Street, Manchester M4 7AJ, United Kingdom (GB)

Inventor

Name:
CHEN, Min-Che
Address:
United Kingdom (GB)

Priority

Priority Number:
0916686
Priority Date:
23/09/2009
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 38/17; A61P 35/00; C07K 14/705; C07K 16/28; G01N 33/50; G01N 33/68;

Publication

European Patent Bulletin

Issue number:
201852
Publication date:
26/12/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages